⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Ampligen Diagnósticos and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Ampligen Diagnósticos
↗Ponferrada, Spain
Ampligen Diagnósticos is a private, independent Spanish laboratory established in 1996. The company specializes in a wide range of genetic services, including paternity testing (private, legal, and prenatal), DNA tests (mitochondrial, X-chromosome, twin studies), HPV detection, and pharmacogenomics.
It is important to distinguish this entity from the US-based biotech company AIM ImmunoTech (formerly Hemispherx Biopharma), which develops a drug also named 'Ampligen' (rintatolimod). Ampligen Diagnósticos operates as a diagnostic service provider in Spain and is not involved in the development of the rintatolimod drug.
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Genetic Testing / Diagnostics
SIZE & FINANCIALS
Employees:1-50
Founded:1996
Ownership:private
Status:operating
0
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Pilar Arca - Director
Scientific Founders:Pilar Arca
LINKS
Website:ampligen.es
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Ampligen Diagnósticos. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.